Danaher Corporation
$ 177.25
-0.74%
24 Apr - close price
- Market Cap 125,452,345,000 USD
- Current Price $ 177.25
- High / Low $ 178.98 / 176.48
- Stock P/E 34.35
- Book Value 74.82
- EPS 5.16
- Next Earning Report 2026-07-21
- Dividend Per Share $1.36
- Dividend Yield 0.76 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.07 %
- 52 Week High 242.28
- 52 Week Low 175.00
About
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Analyst Target Price
$250.14
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-21 | 2026-01-28 | 2025-10-21 | 2025-07-22 | 2025-04-22 | 2025-01-29 | 2024-10-22 | 2024-07-23 | 2024-04-23 | 2024-01-30 | 2023-10-24 | 2023-07-25 |
| Reported EPS | 2.06 | 2.23 | 1.89 | 1.8 | 1.88 | 2.14 | 1.71 | 1.72 | 1.92 | 2.09 | 2.02 | 2.05 |
| Estimated EPS | 1.94 | 2.19 | 1.72 | 1.64 | 1.64 | 2.16 | 1.57 | 1.57 | 1.71 | 1.91 | 1.88 | 2.02 |
| Surprise | 0.12 | 0.04 | 0.17 | 0.16 | 0.24 | -0.02 | 0.14 | 0.15 | 0.21 | 0.18 | 0.14 | 0.03 |
| Surprise Percentage | 6.1856% | 1.8265% | 9.8837% | 9.7561% | 14.6341% | -0.9259% | 8.9172% | 9.5541% | 12.2807% | 9.4241% | 7.4468% | 1.4851% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-21 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.84 |
| Currency | USD |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-24 | 2026-01-30 | 2025-10-31 | 2025-07-25 | 2025-04-25 | 2025-01-31 | 2024-10-25 | 2024-07-26 | 2024-04-26 | 2024-01-26 |
| Amount | $0.4 | $0.32 | $0.32 | $0.32 | $0.32 | $0.27 | $0.27 | $0.27 | $0.27 | $0.24 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: DHR
2026-04-27 10:52:32
The State of Michigan Retirement System reduced its stake in Danaher Corporation (NYSE:DHR) by 4.5% in Q4 2025, selling 7,800 shares to hold 164,546 shares valued at $37.67 million. Despite beating EPS expectations and raising its dividend, Danaher faces several challenges including a $172.5 million litigation settlement, a €3.0 billion senior note issuance, rising short interest, and recent analyst price target trims. Hedge funds collectively own 79.05% of the company's stock, while insiders own 10.80%.
2026-04-27 07:08:23
Advisors Capital Management LLC significantly increased its stake in Danaher Corporation during Q4, now holding 54,845 shares valued at $12.56 million. Other institutional investors also raised their positions, with institutional ownership reaching 79.05%. Danaher recently exceeded EPS estimates, provided FY2026 guidance, and increased its quarterly dividend, though the stock faces mixed analyst sentiment and several near-term risks.
2026-04-27 06:09:59
The global RT-PCR market is projected to reach US$ 2.71 billion by 2031, growing at a CAGR of 7.5% from US$ 4.47 billion in 2024. This growth is driven by the increasing demand for rapid and accurate molecular diagnostics for infectious diseases, oncology, and genetic testing, alongside technological advancements and rising healthcare expenditure. Key players like F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., and QIAGEN N.V. are innovating and expanding their global presence.
2026-04-26 19:18:29
Google's 2026 Discover Core Update is revolutionizing how mobile users get information on stocks like Danaher Corp. (DHR), making insights into life sciences, diagnostics, and biotech trends directly accessible in their feeds. This update leverages individual Web and App Activity to deliver personalized content, enhancing visibility for Danaher's diverse portfolio across biotechnology, diagnostics, and life sciences, emphasizing E-E-A-T content and mobile-optimized formats for investors. The article details how this shift benefits investors by providing real-time, data-rich information on Danaher’s strategy, acquisitions, and financial health, ultimately enabling faster and more informed decisions.
2026-04-26 14:26:58
Agilent Technologies Inc. (NYSE: A) is highlighted as a strong investment due to its leadership in life sciences and diagnostics tools, offering exposure to high-growth sectors like biotech and pharmaceuticals. The company's diversified business segments, strong financial health, and strategic focus on innovation and sustainability contribute to its resilient performance and appeal to investors seeking both growth and income. Agilent’s role in megatrends like personalized medicine and its competitive moat through established brands and recurring revenue from services make it a compelling long-term hold.
2026-04-26 12:24:27
Vanguard Group Inc. increased its stake in Danaher Corporation (NYSE:DHR) by 0.1% in the fourth quarter, now holding 60,978,360 shares valued at approximately $13.96 billion. Despite positive earnings and a dividend increase, Danaher faces near-term headwinds including a $172.5 million shareholder litigation settlement, a €3.0 billion senior notes offering, and increased short interest, which have led to some analyst price target cuts. The company reported EPS of $2.06, beating estimates, and set FY2026 guidance.
